Revisiting The Evidence For Breast Cancer Risk Reduction Following Removal Of Tubes And Ovaries In Patients With BRCA1 And BRCA2 Mutations
Revisiting The Evidence For Breast Cancer Risk Reduction Following Removal Of Tubes And Ovaries In Patients With BRCA1 And BRCA2 Mutations Within a short time after the discovery of the BRCA1 and BRCA2 breast/ovarian cancer genes in the mid-1990s two important facts came to light. First, was that removal of the ovaries impacted the risk…
